){kind=logo}
This is a past event, catch up below
Never has scientific research looked as promising as it does now, with new exciting possibilities for tackling diseases through the development of innovative medicines. The process, from research to use, takes several years and requires the close collaboration of many stakeholders. What is the role of each part of the system – from industry researcher, through the regulating medicines authorities, to NHS clinicians and patients? And, given their differing perspectives, how do these different parts of the system view the future of innovation in research, medicines and the NHS?
This event explored the process of developing new medicines and discussed what access and uptake entail, with experts on hand to answer questions and clarify how the system works at the moment. We discussed the best way forward to make the most of innovation, while maintaining patient safety and clinical standards.
Watch back on demand
Please note, this event was pre-recorded and our speakers were watching along and answered the most popular questions during the livestream on 21st September. The content was pre-recorded before the September 2021 government reshuffle.
Event sponsor
Get in touch about sponsorship and exhibition
If you would like a conversation about your business goals, and how being involved with future events can help you, please email the Partnerships team.
Speakers
-
)
Paula Head
Senior Fellow -
)
Lord Bethell of Romford
Former Parliamentary Under Secretary of State (Minister for Innovation) -
)
Paul Catchpole
Value and Access Policy Director, Association of the British Pharmaceutical Industry (ABPI) -
)
Nick Meade
Joint Interim Chief Executive and Director of Policy, Genetic Alliance UK -
)
Sharmila Nebhrajani OBE
Chairman, National Institute for Health and Care Excellence -
)
Dr Olivia Rossanese
Interim Director of the Cancer Research UK Cancer Therapeutics Unit and Interim Head of the Division of Cancer Therapeutics, The Institute of Cancer Research